Association of minimal-change disease and polycythaemia in a very elderly patient  by Heras, Manuel et al.
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etters to the Editor – Brief Case Reports
ssociation  of minimal-change  disease  and  polycythaemia
n a  very  elderly  patientsociación  de  nefropatía  por  cambios  mínimos  y  policitemia  en  un
it was decided to repeat a second renal biopsy of the right kid-aciente  muy  anciano
o the Editor,
e  report the case of a 85 year old male who was admit-
ed with nephrotic syndrome for study. His medical history
ncluded hypertension, atrial ﬁbrillation, hiatal hernia and
enign prostatic hypertrophy. He had undergone surgery for
olorectal adenocarcinoma in 2006. No history of smoking or
ung disease. He is receiving regular treatment with amlodip-
ne 5 mg/day, enalapril 5 mg/day, dabigatran 110 mg/12 h (for
ast 10 days), tamsulosin 0.4 mg/day, dutasteride 0.5 mg/day
meprazole 40 mg/day. In the 5 days prior to admission,
he patient had come to the emergency room on 2 occa-
ions with edema in hands and legs, and treatment with
urosemide 80 mg  orally was prescribed. Without achieving
linical improvement, he went to the emergency room for a
hird time, and the Department of Nephrology was then con-
ulted for edema and urinalysis with protein +++. On physical
xamination, the patient had an acceptable general condition,
as conscious and responsive. On admission, blood pressure
as 126/78 mmHg, heart rate 73 bpm, and temperature 37 ◦C.
ardiac auscultation was arrhythmic with no murmurs, and
espiratory auscultation presented bibasilar crackles. He had
itting edema (+++/+++) at both limbs. The remainder of the
hysical examination was anodyne. Table 1 shows test results
efore the nephrotic syndrome was detected during a visit to
he ER, at the day of admission, during hospitalization and at
he ﬁrst visit after his discharge from the hospital.
All other blood analytical determinations showed: glu-
ose 100 mg/dl, urea 72 mg/dl, uric acid 7.9 mg/dl, cholesterol
39 mg/dl, LDL-cholesterol 342 mg/dl, HDL cholesterol 75 m/dl,
riglycerides 112 mg/dl, total protein 4.9 mg/dl, calcium 7.6 mg
l, phosphorus 3.6 mg/dl, sodium 127 mmol/l, potassium
.5 mmol/l. Blood electrophoresis showed an increase in 2
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ambios mínimos y policitemia en un paciente muy anciano. Nefrologíand  globulins levels, with a percent decrease in albumin
without monoclonal peaks. Tumor markers (CEA, CA 19.9, PSA)
were within normal limits. Serology for hepatitis B, C and
HIV was negative. Immunological study (C-reactive protein,
rheumatoid factor, ANA, complement and immunoglobu-
lins A and M) was normal. There was a slight decrease
in immunoglobulin G of 730 mg/dl (normal: 751–1560). Vita-
min  B12 and folic acid levels were normal. In urine, the
electrophoretic study showed non-selective proteinuria and
negative Bence-Jones.
Abdominal ultrasound was difﬁcult to assess due to poor
acoustic window: the left kidney had a very difﬁcult viewing
while the right had a normal morphology and echogenicity,
but there was no dilation of the urinary tract. No ﬁndings in the
rest of the ultrasound examination. Venous Doppler in lower
limb excluded DVT.
We proceeded to perform symptomatic treatment of
nephrotic syndrome with intravenous use of 20% albumin
and furosemide 120 mg,  spironolactone 12.5 mg,  enalapril
5 mg/day, atorvastatin 40 mg/day along with enoxaparin
60 mg/day sc. To determine the cause of nephrotic syndrome,
a ﬁrst renal biopsy was performed on the left kidney without
getting sufﬁcient material to establish an etiologic diagnosis
(2 sclerotic glomeruli). After the ﬁrst renal biopsy, empiri-
cal treatment was initiated with prednisone 60 mg/day. The
patient was clinically better, and weight and edema loss
started. However, in the new proteinuria control performed
seven days after starting prednisone, proteinuria remained
above 25 g. Given the histological lack of available information,es MJ, Queizán JA, Callejas R, et al. Asociación de nefropatía por
a. 2016;36:67–69.
ney, ﬁnding “6 glomeruli per slice plane without signiﬁcant
alterations, and tubule-interstitium component and vessels
without ﬁndings”, that is why the patient was diagnosed with
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Table 1 – Basal laboratory values during the diagnosis of nephrotic syndrome and in the ﬁrst outpatient visit after
discharge.
Date 2014 20/3/2015 22/3/2015 24/3/2015 25/3/2015 30/3/2015 06/4/2015 13/4/2015 27/4/2015
Creatinine (mg/dl) 0.7 0.7 0.8 1.1 1.1 0.9 0.9 0.7 1.1
Albumin (g/dl) 4 1.9 2.6 2.8 2.5 3.6
Erythrocytes (×106/l) 5.07 5.97 6.47 6.56 6.66 5.94 6.16 5.81 6.05
Hemoglobin (g/dl) 16.1 18.3 19.5 19.7 20.2 18.2 18.8 17.4 18.6
Hematocrit (%) 47.8 51 54.9 56.9 56.2 52 55.7 51 55.3
Leukocytes (×103/l) 5.49 7.07 8.50 8.35 10.70 7.96 10.11 9.85 8.98
Platelets (×103/l) 133 159 174 174 202 144 208 182 108
Iron (/dl) 132 86 179
Ferritin (ng/ml) 30 362 185
Transferrin (mg/dl) 279 69 165
Systematic urine (proteinuria) (−) +++ +++ +++ +++ +++ (−)
Proteinuriaa (g/24 h) 24.4 26.96 1.90 0.17
CCr (m/min) 85 90 73.5
CCr, creatinine clearance.
r
1a Collected urine in 24 h.
minimal change glomerulonephritis. Given these histologi-
cal ﬁndings, the established treatment with prednisone was
maintained, and 5 days after the second biopsy, proteinuria
was reduced to less than 2 g. With clinical and analytical
improvement, the patient was discharged.
From the ﬁrst visit to the ER, polycythemia was detected,
with the rest of the series in the normal range. The poly-
cythemia has been present during hospitalization and even
on the ﬁrst visit after discharge. Hematology were consulted,
and a blood morphology study was requested (red blood
cells: normocytic–normochromic with ovalocytes presence
and some poikilocytes, white blood cells series: neutrophils
with decreased cytoplasmic granulation; Platelet series: with-
out signiﬁcant morphological alterations); JAK-2 mutations
not detected and exon 12 was negative. By these ﬁndings,
together with the absence of splenomegaly, the polycythemia
was considered spurious. Despite clinical improvement, with
remission of proteinuria, polycythemia persisted, that is why
it was decided to perform a phlebotomy.
The association of nephrotic syndrome and polycythemia
is rare. Less common is minimal change glomerulonephritis,
the cause of nephrotic syndrome in patients with poly-
cythemia. Well, we  are describing a case of this association
in a very elderly patient.
Most cases of nephrotic syndrome and polycythemia doc-
umented in the literature correspond to focal segmental
glomerulosclerosis, mainly related with polycythemia vera,1–3
and, in some isolated cases, with secondary polycythemia,4
Some cases of idiopathic membranous nephropathy and sec-
ondary polycythemia,5,6 are also collected. Regarding the
association of minimal-change disease and polycythemia, as
in our case, in reviewing the literature we have only found
a few casos.7,8 Although nephrotic syndrome occurs in child-
hood, and both entities are treated with glucocorticoids, it is in
the second decade of life, coinciding with a nephrotic relapse
when polycythemia is discovered. In our case, the beginning of
both the nephrotic syndrome and polycythemia occur simul-
taneously and in the eighth decade of life.
In the cases of minimal-change disease and/or membra-
nous nephropathy associated with polycythemia reported
2in the literature, it is established the hypothesis that as a
result of renal hypoxia and increased secretion of interleukin-
8 by the kidney, an overproduction of erythropoietin would
take place, although in some of these cases the levels were
normal and in others they were not available. In our case,
although we do not have the levels of erythropoietin, hav-
ing ruled out the presence of primary polycythemia and
other secondary causes, perhaps this can be explained by the
existence of renal ischemia associated with severe nephrotic
syndrome.
Glucocorticoid therapy in known cases of minimal-change
disease and polycythemia allows the disappearance of pro-
teinuria and the levels of hemoglobin and hematocrit were
maintained within normal range. In our patient, treatment
with corticosteroids allowed a complete remission of protein-
uria and a normalization of the levels of transferrin, while
polycythemia persisted until the ﬁrst outpatient visit, requir-
ing the completion of a phlebotomy as a treatment for this.
In conclusion, we are describing a rare case of minimal-
change disease and secondary polycythemia, with a simulta-
neous onset of both clinical entities in a very elderly patient.
Steroid treatment allowed proteinuria remission and transfer-
rin normalization, but without changes in blood parameters.
A phlebotomy was necessary to correct the problem.
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buprofen-induced  acute  inter
aediatric population
efritis  intersticial  aguda  por  ibup
o the Editor,
cute tubulointerstitial nephritis (ATIN) leads to acute kidney
amage; it has a low incidence in the paediatric population1,2
nd is present in up to 15% of renal biopsies performed in
dults for acute kidney damage.3 Currently, the most com-
on  cause of ATIN is drugs. Other causes include infection,
mmunological disease (such as systemic lupus erythemato-
us or Sjögren’s syndrome), and sometimes the cause is
nknown.4 Several groups of drugs have been identiﬁed
s ethiological agents: antibiotics and non-steroidal anti-
nﬂammatory drugs (NSAIDs), which are extensively used in
outine clinical practice, are among the most frequently impli-
ated in ATIN.5
We  present 3 cases of paediatric patients with non-oliguric
cute kidney damage, seen in our department between 2008
nd 2010, with a working diagnosis of NSAID-induced (ibupro-
en) ATIN.
None of the children had a past history of kidney disease or
ther past medical history of relevance, and all had had blood
ests in the previous months with normal creatinine levels and
he estimated glomerular ﬁltration rate according to the origi-
al Schwartz formula6 were normal. On physical examination,
here were no signs of dehydration, blood pressures were
 Please cite this article as: Martínez-López AB, Álvarez Blanco O, Luq
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tial  nephritis  in the
eno  en  población  pediátrica
normal for the patients’ age, sex, and height, and there was
no oedema. There were no features of obstructive uropathy
or evidence of glomerulopathy (C3 and C4 complement study,
immunoglobulins, and ANA were normal). The 3 patients
had received ibuprofen before developing kidney damage. The
patients’ clinical characteristics and laboratory results are pre-
sented in Table 1.
On admission, ibuprofen treatment was stopped in
patients 1 and 3. Patient 2, who was referred from another
hospital, had stopped the medication 2 days before admission
to our department. Once a diagnosis of ATIN was suspected,
treatment was started with intravenous methylprednisolone
boluses (15 mg/kg/day for 3 consecutive days, accounting for
250–500 mg  iv/day of methylprednisolone) followed by oral
prednisolone (starting dose 1 mg/kg/day) at a reducing dose,
which was then stopped at 8 weeks. None of the patients had
adverse effects attributable to steroids. Urea  and creatinine
returned to normal levels during the ﬁrst week in all 3 cases
(Fig. 1). Urinary biochemistry and sediment returned to normal
within 6 months.
Drug-induced ATIN is the result of a cell-mediated hyper-ue de Pablos A, Morales San-José MD, Rodríguez Sanchez de la
trica. Nefrologia. 2016;36:69–71.
sensitivity reaction to a drug. It occurs independently of the
route of administration (intravenous, intramuscular, oral, or
rectal)4 and the duration of treatment.7 Patients who  have had
